advertisement

Managing Autoimmune Conditions in Pregnancy: Evolving Challenges

managing autoimmune conditions pregnancy

06/04/2025

With the prevalence of autoimmune diagnoses at conception rising among pregnant women, OB/GYN specialists face mounting hurdles in safeguarding both maternal and fetal health.

Recent data reveal that the prevalence of autoimmune conditions in pregnancy has climbed steadily over the past two decades, reflecting a rising incidence among pregnant women.

This shift demands a reevaluation of prenatal care protocols: practitioners must now factor in the risk of autoimmune disease flares during pregnancy, which amplify the likelihood of disease flares, preterm birth, and hypertensive complications that threaten maternal health and fetal outcomes.

Managing autoimmune conditions during pregnancy now relies on personalized regimens that balance maternal disease control with fetal safety, as outlined in the American College of Obstetricians and Gynecologists' Committee Opinion No. 776 on immune-modulating therapies in pregnancy and lactation. These guidelines emphasize careful adjustment of autoimmune medications in prenatal care, including substituting teratogenic agents and optimizing dosing schedules, alongside continuous monitoring to mitigate pregnancy autoimmune risk.

Earlier insights underscore the value of collaborative care models: regular assessment of inflammatory markers, joint decision-making between rheumatology and obstetrics teams, and patient education form the backbone of effective management.

As OB/GYN specialists integrate these evolving approaches, key questions remain about the long-term outcomes of current strategies across diverse populations, highlighting areas for future investigation.

Key Takeaways:
  • The prevalence of autoimmune conditions in pregnancy is increasing, reshaping maternal-fetal care practices.
  • Managing these conditions requires personalized adjustments to medication and continuous monitoring for optimal outcomes.
  • Current trends suggest an urgent need to revisit existing prenatal care protocols to accommodate the rising incidence.
  • Future research should focus on the long-term effects of management strategies on diverse populations.
Register

We're glad to see you're enjoying Rheumatology Academy…
but how about a more personalized experience?

Register for free